Health informatics

How AI is changing cancer research, the site perspective, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, October 9, 2023
Patient, AI, Senior, Product management, Face, Clinical trial, Marker beacon, RN, Health informatics, Ohio State University, Medical device, Medical imaging, Customer service

TORONTO, Oct. 9, 2023 /PRNewswire-PRWeb/ -- Oncology sites across the US are investing in AI to drive operational performance in the face of complex protocols, stringent eligibility criteria, high rates of protocol deviations and high dropout rates.

Key Points: 
  • In this free webinar, get an inside look at how an oncology research site is using AI to address the complexities of oncology study operations.
  • Attendees will learn how to improve protocol design and feasibility to avoid downstream challenges at the site.
  • The speakers will also discuss how sites are managing AI technologies and upskilling clinical research coordinators (CRCs) to improve recruitment.
  • Join this webinar for an inside look at how an oncology research site is using AI to address the complexities of study operations.

Alacrita Consulting Promotes Saadia Basharat & Jess Hearn-Messenger to Principals

Retrieved on: 
Thursday, October 5, 2023
Jess, University of Leicester, Doctor of Philosophy, Lead, Imperial College London, Health informatics, Master of Science, Therapy, WMG, University of Warwick, University, Systems biology, Growth, VCS, Biochemistry, Monte Carlo, Pharmaceutical industry, Nursing, Neuroendocrinology, Saadia Gaon, Molecular medicine

LONDON, Oct. 5, 2023 /PRNewswire/ -- Alacrita Consulting, a leading pharmaceutical and biotech consulting firm headquartered in London, today announces the promotions of Saadia Basharat, PhD, and Jess Hearn-Messenger, PhD, both to Principal.

Key Points: 
  • LONDON, Oct. 5, 2023 /PRNewswire/ -- Alacrita Consulting, a leading pharmaceutical and biotech consulting firm headquartered in London, today announces the promotions of Saadia Basharat, PhD, and Jess Hearn-Messenger, PhD, both to Principal.
  • In recognition of her successful transition to San Diego, as Alacrita's Head of West Coast Consulting, she has been made a Principal of the firm.
  • We are delighted to promote her to Principal," said Alastair Southwell, Managing Partner at Alacrita Consulting.
  • Additional information on Saadia Basharat, PhD, Principal: https://www.alacrita.com/consultants/saadia-basharat
    Additional information on Jess Hearn-Messenger, PhD, Principal: https://www.alacrita.com/consultants/jess-hearn-messenger

Alacrita Consulting Promotes Saadia Basharat & Jess Hearn-Messenger to Principals

Retrieved on: 
Thursday, October 5, 2023
Jess, University of Leicester, Doctor of Philosophy, Lead, Imperial College London, Health informatics, Master of Science, Therapy, WMG, University of Warwick, University, Systems biology, Growth, VCS, Biochemistry, Monte Carlo, Pharmaceutical industry, Nursing, Neuroendocrinology, Saadia Gaon, Molecular medicine

LONDON, Oct. 5, 2023 /PRNewswire/ -- Alacrita Consulting, a leading pharmaceutical and biotech consulting firm headquartered in London, today announces the promotions of Saadia Basharat, PhD, and Jess Hearn-Messenger, PhD, both to Principal.

Key Points: 
  • LONDON, Oct. 5, 2023 /PRNewswire/ -- Alacrita Consulting, a leading pharmaceutical and biotech consulting firm headquartered in London, today announces the promotions of Saadia Basharat, PhD, and Jess Hearn-Messenger, PhD, both to Principal.
  • In recognition of her successful transition to San Diego, as Alacrita's Head of West Coast Consulting, she has been made a Principal of the firm.
  • We are delighted to promote her to Principal," said Alastair Southwell, Managing Partner at Alacrita Consulting.
  • Additional information on Saadia Basharat, PhD, Principal: https://www.alacrita.com/consultants/saadia-basharat
    Additional information on Jess Hearn-Messenger, PhD, Principal: https://www.alacrita.com/consultants/jess-hearn-messenger

Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors

Retrieved on: 
Monday, October 2, 2023
Health informatics, Most, Office of the National Coordinator for Health Information Technology, Franciscan Missionaries of Our Lady University, University, Accreditation, Emergency medicine, Office of Inspector General, U.S. Department of Health and Human Services, Policy, Blue Cross Blue Shield Association, Pennsylvania State University, Harvard University School of Mining and Practical Geology, Medicine, Research, Pharmacy, Private practice, Health, TCMD, Public health, Alphabet, Principal, Raffles Medical Group, Nursing, Health care

MINNEAPOLIS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Vindell Washington, M.D.

Key Points: 
  • MINNEAPOLIS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Vindell Washington, M.D.
  • to the Company’s Board of Directors (“Board”), effective October 2, 2023.
  • “We are pleased to welcome Dr. Washington to Tactile Medical, who joins our Board with over 30 years of experience in the healthcare industry,” said Bill Burke, Chairman of the Board of Tactile Medical.
  • in Healthcare Management from the Harvard University School of Public Health.

Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education

Retrieved on: 
Thursday, September 28, 2023
University, Biotechnology, Education, Other Health, Health, General Health, Pharmaceutical, Health Technology, Other Science, Research, Science, LaGuardia Community College, Workforce, CUNY, Therapy, Curriculum, National Science Foundation, Principal investigator, Health informatics, Associate, Student, New York City College of Technology, Underrepresented group, Chemistry, Drug discovery, City University of New York, Growth, Environment, Empowerment, City University, Nursing, LaGuardia Airport, STEM

The grant will help increase access for underrepresented students to industry-leading technology and paid internships to prepare them for careers in drug discovery.

Key Points: 
  • The grant will help increase access for underrepresented students to industry-leading technology and paid internships to prepare them for careers in drug discovery.
  • Schrödinger and two academic collaborators City Tech and LaGuardia will use the funding to launch a collaborative initiative, Introducing Molecular Modeling Experiences to underRepresented StudEnts (IMMERSE).
  • “The IMMERSE initiative affords an unprecedented environment to empower associate degree students with molecular modeling skills that are key for the workforce.
  • We are delighted to work closely with City Tech and Schrödinger to improve educational pathways and provide career opportunities in the biotechnology area.”

Inovalon to Host Customer Congress in Washington, D.C. October 15-17, 2023

Retrieved on: 
Monday, September 25, 2023
Senior, Health, Pharmacy, Health informatics, Medicine, Harvard Medical School, Organization, Congress, Pharmacist, Corporation, Digital, Economics, Management, Inovalon, Microsoft

BOWIE, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software empowering data-driven healthcare, today announced that its annual Customer Congress will take place from October 15-17, 2023 in Washington, D.C.

Key Points: 
  • BOWIE, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software empowering data-driven healthcare, today announced that its annual Customer Congress will take place from October 15-17, 2023 in Washington, D.C.
  • This year’s Customer Congress is a significant milestone as Inovalon celebrates 25 years of partnering with customers to improve clinical outcomes and economics across healthcare.
  • Chair, Department of Biomedical Informatics, Harvard Medical School; Katya Andresen, Senior Vice President and Chief Digital & Analytics Officer, The Cigna Group; Rajesh Viswanathan, Chief Technology Officer, Inovalon; Eron Kelly, President, Inovalon; and Keith R. Dunleavy, M.D., Founder and CEO, Inovalon.
  • “Collaboration is key to inspiring innovation and driving meaningful industry change, making this year’s congregation of the most forward-looking individuals and organizations in healthcare and technology especially valuable.”
    To learn more about the event and to register, please visit: 2023 Inovalon Customer Congress .

MEDIA ALERT: WEBINAR: Ask Me Anything: Dr. David Clark on the Power of Measurement-based Care

Retrieved on: 
Tuesday, September 19, 2023
General Health, Mental Health, Other Health, Health, Practice Management, Knowledge, University, NHS, Partnership, Health informatics, MBC, Q&A, Psychology, Experimental psychology, Nursing, Session

To register for this webinar, please visit greenspacehealth.com/events .

Key Points: 
  • To register for this webinar, please visit greenspacehealth.com/events .
  • This virtual event is intended for a broad audience of behavioral health leaders and providers with varying levels of MBC knowledge.
  • Attendance at Session #1 is not required to register for this session.
  • Click below to explore key highlights from Session #1:

CVS Health appoints Michael F. Mahoney to its Board of Directors

Retrieved on: 
Thursday, September 21, 2023
Health informatics, University, Medical device, Diagnosis, Wake Forest University, BSX, Health, Endoscopy, The Advisory Board Company, Baxter International, Patient, Electrophysiology, Boston College, Johnson & Johnson, CVS Health, Boy, NYSE, Urology, Independent, Worldwide, Management, Nursing, Pharmaceutical industry, Boston Scientific

WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1.

Key Points: 
  • WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1.
  • "Mike's focus throughout his career – to drive improvements in health outcomes and increase access to care – align with our mission at CVS Health," said CVS Health President and CEO Karen S. Lynch.
  • Mahoney became the CEO of Boston Scientific Corporation in 2012 and became Chairman of the company's Board of Directors in 2016.
  • "We're extremely pleased to have Mike join the Board," said Roger N. Farah, Independent Chair of the Board of CVS Health.

The New York Academy of Medicine Announces 2023 Annual Award Recipients

Retrieved on: 
Thursday, September 7, 2023
Panzi Hospital, New York Academy of Medicine, Harvey V. Fineberg, NYAM, University, Health policy, Population health, Face, CNM, Public, University of Washington, COVID-19, Department of Medicine – University of Pamplona, FACC, Health equity, Biomedical Research, Health informatics, Hope, Woman, CPA Donald O. Hebb Award for Distinguished Contributions to Psychology as a Science, MBA, Research, Genomics, Doctor of Philosophy, Feinberg School of Medicine, MACP, NHGRI, Social justice, Democratic republic, Work, FAHA, Biomedicine, Diversity, Informatics, Inclusion, American Cancer Society, Health, MPH, NIH, Breast cancer, Pharmaceutical industry, Nursing, Beauty salon, Management, MD, Cardiology, Medicine

New York, NY, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM) will present its prestigious, historic annual awards at a virtual event on Wednesday, September 27, 2023.

Key Points: 
  • New York, NY, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM) will present its prestigious, historic annual awards at a virtual event on Wednesday, September 27, 2023.
  • Recipients of this award over the years have included Katalin Karikó and Drew Weissman, Elaine Fuchs, Harold Varmus, David Biltmore, and Réne Dubos.
  • Recent recipients of this award over the years include Kizzmekia Corbett, Barney Graham, William Gruber, Philip A. Pizzo, and David Hamburg.
  • Recent recipients of this award over the years include James Flynn, George E. Thibault, Claire Fagin, and Margaret Mahoney.

BC Platforms Appoints Dr. Ben Illigens as Chief Medical Officer

Retrieved on: 
Thursday, September 7, 2023
Real, Heart, Data science, Cardiac surgery, Health informatics, VP/CSS, Dakota Freie Presse, CMO, Research, Practice, Real world data, BCP, Harvard Medical School, Public sector, Doctor, Genomic and medical data, Clinical research, International University, Informatics, Drug discovery, Neurology, Biostatistics, HMS, Health, Medicine, Pharmaceutical industry, Nursing, Neuroscience

ZURICH, Switzerland, Sept. 07, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Dr. Ben M. W. Illigens, an experienced clinician and neuroscientist, as the company’s Chief Medical Officer.

Key Points: 
  • ZURICH, Switzerland, Sept. 07, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Dr. Ben M. W. Illigens, an experienced clinician and neuroscientist, as the company’s Chief Medical Officer.
  • Dr. Ben M. W. Illigens, newly appointed Chief Medical Officer at BC Platforms, commented on his appointment, “I am delighted to join the BC Platforms team.
  • I’ve long been fascinated by, and closely involved with, ways to optimize, accelerate, and innovate drug discovery and development using a data-driven, evidence-based, patient-centered approach.
  • He conducted clinical practice and research at HMS, and has over 60 peer-reviewed publications, including editing a core medical textbook on Clinical Research (1).